Cerenome
Tracked across 2 events · 12 articles · First seen Jul 31, 2026 · Last active Sep 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Cerenome is the new corporate identity of MiNK Therapeutics, effective August 3, 2026. It will trade under the ticker CNSY and aims to integrate diagnostics, therapeutics, and AI to improve CNS cancer care, potentially enhancing its market position.
Jul 31, 2026 · 6 articles
Business
Cerenome, Inc. (Nasdaq: CNSY), a clinical-stage CNS oncology company, announced on September 10, 2026 that it entered into a financing agreement with 3i, LP for a senior secured facility of up to $20 million with…
Impact: Cerenome is the borrower and central party of the event, securing up to $20 million in non-dilutive capital that extends its cash runway into 2028 and funds CNSide commercialization.
Sep 10, 2026 · 6 articles
95
Cerenome entered financing agreement 3iCerenome Secures $20M 3i...
80
3i provided initial funding CerenomeCerenome Secures $20M 3i...
ERGEN INTELLIGENCE
Track Cerenome live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard